logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xiaohua Wu

fudan university
H指数:35
被引数:3,895
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study

fruquintinib 联合 sintilimab 治疗晚期宫颈癌：一项开放标签、多中心、II 期研究

Communications Medicine
IF6.3
2026-04-210
OAAI
Xiaohua Wu; Danbo Wang; Jing Wang; Yi Huang; Tienan Yi; Guiling Li; Jieqing Zhang; Keming Wang; Yu Kang; Anwen Liu; Xiaotian Han; Xuemei Ren; Li Li; Runfeng Yang; Quan Li; Qing Yang; Bingbing Zhao; Juan Wang; Hanjie Yi; Yue Tan; Keyan Chen; Puhan Lu; Haiyan Shi; Panfeng Tan; Songhua Fan; Michael M. Shi; Weiguo Su
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial

fruquintinib 联合 sintilimab 治疗错配修复 proficient 状态的晚期子宫内膜癌患者：一项多中心、单臂、 Ib/II 期临床试验

Nature Communications
IF15.7
2025-12-210
OAAI
Xiaohua Wu; Jing Wang; Danbo Wang; Guiling Li; Jieqing Zhang; Hongmin Chen; Hongying Yang; Qi Zhou; Ke Wang; Yumei Wu; Tienan Yi; Jihong Liu; Yi Huang; Yuxian Bai; Keming Wang; Kui Jiang; Hanmei Lou; Ruifang An; Xiumin Li; Yueyin Pan; Yue Wang; Weiping Tao; Kun Song; Yu Kang; Yuzhi Li; Wenyu Shi; Anwen Liu; Ying Yang; Yijun Wang; Keyan Chen; Haiyan Shi; Puhan Lu; Panfeng Tan; Songhua Fan; Michael Shi; Weiguo Su
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: 1-Year Follow-Up After Final Analysis of the ENGOT-en9/LEAP-001 Phase 3 Trial

一线仑伐替尼联合帕博利珠单抗与化疗治疗晚期子宫内膜癌：ENGOT-en9/LEAP-001 III期试验最终分析后的1年随访

International Journal of Gynecological Cancer
IF4.7
2025-11-110
PRE
Christian Marth; Richard G. Moore; Mariusz Bidziński; Vanda Salutari; Özden Altundağ; Maria Jesús Rubio; Tally Levy; Alison Stillie; Christof Vulsteke; Ralf Witteler; Kazuya Ariyoshi; Xiaohua Wu; Sophia Frentzas; André Mattar; Brian M. Slomovitz; Stephanie Lheureux; Xiaojun Chen; Kosei Hasegawa; Manuel Magallanes; Chel Hun Choi
Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses

超敏检测和追踪循环肿瘤DNA以预测局部晚期宫颈癌患者的复发和生存：III期CALLA试验分析

Annals of Oncology
IF65.4
2025-06-020
OAAI
J. Mayadev; J.C. Vázquez Limón; F.J. Ramírez Godinez; M. Leiva; L.D.C. Cetina-Pérez; S. Varga; A. Molina Alavez; A.E. Alarcon-Rozas; N. Valdiviezo; C. Acevedo; A. Figueroa; A. Santini; L. Vera; F. Rey; Z. Kahán; P. Galaz; G. Meléndez Mier; X. Wu; M. Mandai; R. Shapira-Frommer; M.D.P. Estevez-Diz; S. Limaye; W. Xin; H. Dry; M.A.S. Broggi; D.Y. Yuan; R.A. Stewart; B.J. Monk
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
NATURE MEDICINE
IF50
2024-05-154
PRE
Wu, Xiaohua; Liu, Jihong; Wang, Jing; Wang, Li; Lin, Zhongqiu; Wang, Xiaobin; Zhu, Jianqing; Kong, Beihua; Fei, Junwei; Tang, Ying; Xia, Bairong; Liang, Zhiqing; Wang, Ke; Huang, Yi; Zheng, Hong; Lin, An; Jiang, Kui; Wang, Wei; Wang, Xin; Lou, Ge; Pan, Hongming; Yao, Shuzhong; Li, Guiling; Hao, Min; Cai, Yunlang; Chen, Xuejun; Yang, Zhijun; Chen, Youguo; Wen, Hongwu; Qu, Pengpeng; Xu, Cong; Hsieh, Chih-Yi

研究方向

暂未获取到该数据
X
Xiao‐Nong Zhou
H 指数:76论文数:779被引数:2.3万
H
Hao Wen
H 指数:31论文数:169被引数:3,217
K
Kui Yu
H 指数:57论文数:238被引数:1.0万
J
Jianqing Zhu
H 指数:24论文数:201被引数:2,267
X
Xingzhu Ju
H 指数:22论文数:78被引数:1,275
Y
Yi Huang
H 指数:17论文数:91被引数:1,546
J
Jianying Ouyang
H 指数:28论文数:70被引数:2,137
X
Xiaojun Chen
H 指数:39论文数:336被引数:4,701
J
Jing Xu
H 指数:31论文数:193被引数:3,262
D
Donald M. Leek
H 指数:26论文数:105被引数:2,298